Answers are grounded in this paper and cite their sources.
For patients with resectable GCTB, neoadjuvant denosumab therapy resulted in beneficial surgical downstaging, including either no surgery or a less morbid surgical procedure.
No takes yet. Share an insight, caveat, or question.
Rutkowski et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: